Physician profile
Stephen Humbert
NPI 1871595041
$4,199.25
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,471 · 2020: $1,212 · 2021: $1,349 · 2022: $166.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $652.61 | 2019-2021 | |
| Novo Nordisk INC | $493.96 | 2019-2022 | |
| Amarin Pharma, INC. | $426.95 | 2019-2021 | |
| Glaxosmithkline, LLC. | $394.85 | 2019-2022 | |
| Abbvie INC. | $292.58 | 2021 | |
| Lilly USA, LLC | $243.10 | 2019-2022 | |
| Allergan, INC. | $242.95 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $201.37 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $181.86 | 2019-2022 | |
| Astellas Pharma US INC | $179.94 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $165.87 | 2019-2022 | |
| Amgen INC. | $103.28 | 2019 | |
| Novartis Pharmaceuticals Corporation | $102.50 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $59.23 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $50.91 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $44.81 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.69 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $40.58 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.50 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $31.78 | 2019-2020 | |
| Vivus LLC | $31.56 | 2019 | |
| Alexion Pharmaceuticals, INC. | $29.84 | 2021 | |
| Eisai INC. | $21.42 | 2021 | |
| Cmp Pharma, INC. | $18.72 | 2021 | |
| Sanofi Pasteur INC. | $17.42 | 2019 | |
| Optos, INC. | $17.41 | 2020 | |
| Adlon Therapeutics L.P. | $17.40 | 2019 | |
| Almatica Pharma LLC | $17.37 | 2021 | |
| Scilex Pharmaceuticals INC. | $16.56 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $12.91 | 2021 | |
| Philips North America LLC | $11.32 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Humbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.